Special Access Scheme approvals for medicinal cannabis in October exceeded 12,000 for the second month running, but fell short of setting another record, according to preliminary data from the Therapeutic Goods Administration (TGA).
Oil represented 55% of the SAS-B approvals in October, according to preliminary data from the TGA
Although the number of approvals has not been formally published, the new TGA medicinal cannabis dashboard says there were 12,206 SAS-B approvals last month. In September there were 13,666 approvals.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and
international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.
Elementum integer enim neque volutpat ac tincidunt vitae semper quis. Eu lobortis elementum nibh tellus molestie nunc. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Magnis dis parturient montes nascetur ridiculus. Dui id ornare arcu odio ut sem. Nisl nunc mi ipsum faucibus vitae.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Steve has reported for a number of consumer and B2B titles over a journalism career spanning more than three decades.
He is a regulator contributor to health journal, The Medical Republic, writing on...
More by Steve Jones